Leverage our end-to-end PGx solutions for clinical trials
A trustworthy PGx Laboratory Partner
Pharmacogenomics (PGx) testing is an increasingly important tool for clinical trial enrollment, interpretation of clinical data and retrospective studies. We offer PharmacoScanTM assay, PharmacoFocusTM assay, custom genotyping panel, and next generation sequencing (NGS) services for clinical trials and drug development. RPRD is a recognized leader in precision medicine research and clinical testing, bringing deep expertise and an unparalleled testing and data analysis service to organizations conducting clinical trials and drug development.
A full portfolio of genetic technology platforms, including next generation sequencing (NGS), microarray, real time PCR, etc.
Decades of experience in genomic research and clinical diagnostic testing
Compliance with HIPPA standard
Industry-leading data security
100% customer satisfaction guaranteed
High Quality Testing Service and Support
We are committed to offer the best quality testing and unparalleled supporting service, using NGS, microarray assays (e.g. PharmacoScanTM , PharmacoFocusTM, UK Biobank assay, etc.), real time PCR, etc.
Most comprehensive coverage of PGx genes and alleles
Thorough analysis of SNPs, Indels, CNVs, translocations, etc.
>99.5% specificity and sensitivity
Clinical diagnostic-grade quality safeguarded by robust quality control system
Comprehensive PGx microarray analysis and next generation sequencing (NGS)
A dedicated project manager supporting the whole project
Customized, end-to-end PGx solutions
We offer customized and end-to-end precision medicine solutions by leveraging our decades of experience in genomics translational research and clinical testing. We specialize in high-quality data analysis and clinical interpretation to help our partners develop better therapies for tomorrow. We provide precision medicine consulting services at each stage of a project to help guide our partners during the development process.
ABC transporter (e.g. ABCB1, ABCG2)
SLC (e.g. SLCO5A1, SLC6A4),
KCNQ1, CFTR, HBB, etc.
State-of-the-art PGx technologies
We offer comprehensive genomic profiling of clinical trial samples in our CLIA-certified laboratory utilizing our comprehensive genomic profiling tests based on Next Generation Sequencing (NGS) and the GeneTitan microarray platform.
PharmacoScanTM and PharmacoFocusTM are ideal genotyping assays for translational researchers in pharma and research organizations looking to understand how genetic variations affect drug absorption, distribution, metabolism, and excretion (ADME).
We can precisely and reproducibly analyze nearly 1,200 genes using PharmacoScanTM and over 150 genes using PharmacoFocusTM.
The assays include detecting copy number variation (CNV) and interrogating predictive markers in complex genes (e.g. CYP2D6).
Unlike other platforms that analyze only the common markers, our comprehensive testing approach presents a more complete view of genotype information that potentially lead to more accurate PGx risk evaluation.